Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Results 151 - 160 of 202 for excel. (0.16 seconds)

Nanjing Frontier Biotechnologies has begun a Phase III...
Bayer HealthCare and Peking University of Beijing will...
Shanxi Taxus Pharma announced plans to take over Cardium...
Shanghai-based PhageLux has received an investment from...
BioLight Israeli Life Sciences Investments reported that...
China announced a new $3.2 billion program to fund...
China is Asia’s number one biopharma cluster,...
Techne will acquire Shanghai PrimeGene Bio-Tech, a...
WuXi PharmaTech and TaiMed Biologics of Taiwan today...
prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | next
Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here